$98.3 Million is the total value of Belmont Global Advisors, Inc.'s 58 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SSB | SOUTH ST CORP | $242,000 | -11.0% | 3,775 | 0.0% | 0.25% | -30.1% | |
| NLY | ANNALY CAP MGMT INC | $190,000 | +9.2% | 18,500 | 0.0% | 0.19% | -14.2% | |
| CBZ | CBIZ INC | $151,000 | +2.0% | 15,000 | 0.0% | 0.15% | -19.8% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-05-16
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ZIOPHARM ONCOLOGY INC | 12 | Q3 2016 | 21.1% |
| INTREXON CORP | 12 | Q3 2016 | 13.1% |
| FACEBOOK INC | 12 | Q3 2016 | 3.4% |
| PIMCO DYNAMIC INCOME FD | 11 | Q3 2016 | 2.2% |
| SYNERGY PHARMACEUTICALS DEL | 11 | Q3 2016 | 1.4% |
| CBIZ INC | 11 | Q2 2016 | 0.2% |
| ZIOPHARM ONCOLOGY INC | 10 | Q3 2016 | 14.8% |
| LA JOLLA PHARMACEUTICAL CO | 10 | Q2 2016 | 3.4% |
| APPLE INC | 10 | Q3 2016 | 3.2% |
| MEDGENICS INC | 10 | Q2 2016 | 2.1% |
View Belmont Global Advisors, Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2016-11-14 |
| 13F-HR | 2016-08-15 |
| 13F-HR | 2016-05-16 |
| 13F-HR | 2016-02-16 |
| 13F-HR | 2015-11-16 |
| 13F-HR | 2015-08-14 |
| 13F-HR | 2015-05-15 |
| 13F-HR | 2015-02-17 |
| 13F-HR | 2014-11-14 |
| 13F-HR | 2014-08-14 |
View Belmont Global Advisors, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.